These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8092757)

  • 1. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
    Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M
    Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex steroid hormones and receptors in relation to S-phase fraction and ploidy level in endometrial carcinoma.
    Boman K; Mäentausta O; Bäckström T; Strang P; Stendahl U
    Anticancer Res; 1995; 15(3):999-1002. PubMed ID: 7645992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of steroid hormone receptors with the biochemical DCC method in endometrial cancer and tumor margin-endometrium relations to cellular changes and hormone level].
    Martin R; Köhler U; Krug H; Rotzsch W
    Geburtshilfe Frauenheilkd; 1993 May; 53(5):314-20. PubMed ID: 8514102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
    Leers MP; Nap M
    Breast J; 2001; 7(4):249-59. PubMed ID: 11678803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective multicenter validation confirms the prognostic superiority of the endometrial carcinoma prognostic index in international Federation of gynecology and obstetrics stage 1 and 2 endometrial carcinoma.
    Baak JP; Snijders W; van Diermen B; van Diest PJ; Diepenhorst FW; Benraadt J
    J Clin Oncol; 2003 Nov; 21(22):4214-21. PubMed ID: 14615450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA flow cytometry in uterine endometrial carcinoma.
    Jacobsen M; Høyer M; Bentzen SM; Nielsen K
    APMIS Suppl; 1991; 23():107-12. PubMed ID: 1883634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between DNA ploidy and functional estrogen receptors in operable prostate cancer.
    Nativ O; Umehara T; Colvard DS; Therneau TM; Farrow GM; Spelsberg TC; Lieber MM
    Eur Urol; 1997; 32(1):96-9. PubMed ID: 9266239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
    Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Degree of DNA ploidy and steroid hormone receptors as prognostic factors in endometrial carcinoma].
    Köhler U; Martin R; Krug H; Bilek K
    Zentralbl Gynakol; 1991; 113(20):1086-95. PubMed ID: 1746194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of prognostic parameters in colorectal carcinoma. II. Ploidy determination with flow cytometry].
    Lanza G; Maestri I; Dubini A; Gafà R
    Pathologica; 1994 Feb; 86(1):30-42. PubMed ID: 8072799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
    Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
    Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic significance of cell kinetic parameters of endometrial cancer].
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of DNA ploidy, steroid hormone receptors, and CA 125 as prognostic factors in ovarian carcinoma: a prospective study.
    Eissa S; Khalifa A; Laban M; Mohamed MK; Elian A
    Nutrition; 1995; 11(5 Suppl):622-6. PubMed ID: 8748237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Numerical aberrations of chromosomes 1 and 7 by fluorescent in situ hybridization and DNA ploidy analysis in breast cancer.
    Kapranos N; Kounelis S; Karantasis H; Kouri E
    Breast J; 2005; 11(6):448-53. PubMed ID: 16297090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.